First Trust NYSE Arca Biotechnology Index Fund
231 hedge funds and large institutions have $908M invested in First Trust NYSE Arca Biotechnology Index Fund in 2021 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 52 increasing their positions, 91 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
2% less funds holding
Funds holding: 235 → 231 (-4)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
43% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 91
Holders
231
Holding in Top 10
3
Calls
$1.97M
Puts
$1.16M
Top Buyers
| 1 | +$5.33M | |
| 2 | +$4.72M | |
| 3 | +$4.03M | |
| 4 |
Morgan Stanley
New York
|
+$2.99M |
| 5 |
TC
TownSquare Capital
Provo,
Utah
|
+$2.09M |
Top Sellers
| 1 | -$344M | |
| 2 | -$9.11M | |
| 3 | -$8.63M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$6.82M |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$6.53M |